LFVN Lifevantage Corp


$ 9.24 $ 0.22 (2.44 %)    

Tuesday, 14-Oct-2025 12:43:47 EDT
QQQ $ 602.01 $ 6.79 (1.14 %)
DIA $ 463.90 $ 6.87 (1.5 %)
SPY $ 664.92 $ 7.62 (1.16 %)
TLT $ 90.69 $ 0.06 (0.06 %)
GLD $ 381.17 $ 2.92 (0.77 %)
$ na
$ 9.00
$ 9.24 x 28
$ 9.30 x 26
$ 9.00 - $ 9.24
$ 8.80 - $ 27.12
108,332
na
114.98M
$ 0.36
$ 11.73
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 correction-on-september-4-2025-lifevantage-reported-that-it-sees-fy2026-adj-eps-100-115-vs-100-est-sees-sales-225000m-240000m-vs-252400m-est

Lifevantage (NASDAQ:LFVN) is looking for FY2026 Adj EPS of $1.00-$1.15 vs $1.00 analyst estimate. sees sales of $225.000 millio...

 lifevantage-q4-adj-eps-017-beats-015-estimate-sales-55114m-miss-56900m-estimate

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.15 by ...

 lifevantage-acquires-lovebiome-terms-not-disclosed

SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company ...

 lifevantage-raises-fy2025-adj-eps-guidance-from-070-080-to-072-088-vs-078-est-lowers-fy2025-sales-guidance-from-23500m-24500m-to-22800m-23500m-vs-23974m-est

Lifevantage (NASDAQ:LFVN) raises FY2025 Adj EPS guidance from $0.70-$0.80 to $0.72-$0.88 vs $0.78 analyst estimate. Lowers FY20...

 lifevantage-q3-eps-026-beats-014-estimate-sales-5840m-miss-6096m-estimate

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.14 by ...

 lifevantage-board-raises-quarterly-cash-dividend-by-125-to-from-004-to-0045-per-share

LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health ...

 lifevantage-q2-earnings-insights
Lifevantage: Q2 Earnings Insights
02/05/2025 21:51:59

 lifevantage-affirms-fy2025-sales-guidance-from-23500m-24500m-to-23500m-24500m-vs-23848m-est

Lifevantage (NASDAQ:LFVN) affirms FY2025 sales outlook from $235.00 million-245.00 million to $235.00 million-245.00 million vs...

 lifevantage-q2-adj-022-beats-013-estimate-sales-6776m-beat-6739m-estimate

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.13 by ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION